Trust Investment Advisors Buys Shares of 6800 Hill-Rom Holdings Inc (HRC)

Trust Investment Advisors Buys Shares of 6800 Hill-Rom Holdings Inc (HRC)

Rothschild Asset Management Inc says it raised its investment in Hill-Rom Holdings Inc shares by 3.0% in the last quarter.

Other institutional investors also recently bought and sold shares of the company.

Other large investors also recently added to or reduced their stakes in the company. Seven Eight Capital LP purchased a new stake in Hill-Rom Holdings during the 2nd quarter worth about $127,000. Zacks Investment Research raised shares of Hill-Rom Holdings from a "hold" rating to a "buy" rating and set a $90.00 price objective on the stock in a report on Friday, October 27th. Investment Counselors of Maryland LLC now owns 2,830 shares of the medical technology company's stock worth $175,000 after buying an additional 377 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Hill-Rom Holdings by 10.2% during the 2nd quarter. Insiders own 2.20% of the company's stock. Citigroup Inc. raised its stake in Hill-Rom Holdings by 21.1% during the 2nd quarter.

The company is up by 0.25% percent from yesterday's close. 564,800 shares of the company's stock traded hands, compared to its average volume of 511,942. The stock has a market capitalization of $5,018.79, a price-to-earnings ratio of 19.74, a P/E/G ratio of 1.62 and a beta of 1.19. Following the transaction, the chief operating officer now owns 22,163 shares in the company, valued at approximately $1,214,089.14. Hill-Rom Holdings Inc has a 52 week low of $52.58 and a 52 week high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Thursday, November 3rd. During the same quarter in the previous year, the firm posted $1.18 earnings per share. The firm had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. Shareholders of record on Friday, December 15th will be issued a $0.18 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date is Thursday, December 14th. Hill-Rom Holdings's dividend payout ratio (DPR) is presently 36.18%. The shares were sold at an average price of $77.48, for a total transaction of $532,287.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at $1,293,993.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

In related news, SVP Andreas G. Frank sold 3,940 shares of the business's stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60.

Several firms have shifted positions in (HRC). BidaskClub cut shares of Hill-Rom Holdings from a "strong-buy" rating to a "buy" rating in a research note on Monday, July 24th.

Equity analyst Needham & Company LLC lowered the price target on November 6 changing the price objective from $93.00 to $90.00 and issued a "Buy" recommendation. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock.

October 17 investment analysts at KeyCorp made no change to the company rating of "Buy" targeting a price of $82.00. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & worldwide trademark & copyright law. Los Angeles Capital Management & Equity Research Inc.'s holdings in Hill-Rom Holdings were worth $390,000 as of its most recent filing with the SEC. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas.